Clinical Trial Update: Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic Predictors

View source ↗

Summary

A completed clinical study evaluating ten-year persistence of biologic therapies in psoriasis and psoriatic arthritis and how genetic and cardiometabolic factor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Psoriatic Arthritis

Snippet

Sponsor: Juan Ruano Ruiz | Conditions: Psoriasis, Psoriatic Arthritis (PsA) | Status: COMPLETED